Do you have generalised epilepsy with uncontrolled seizures?

A study to evaluate the efficacy and saftey of Lacosamide as adjunctive therapy

This study is testing a new treatment for generalised epilepsy with uncontrolled primary generalised tonic-clonic (PGTC) seizures - sometimes also referred to as Grand-Mal seizures. The new treatment is called Lacosamide. This is a double-blind, randomized, placebo-controlled, parallel-group, multicentre study.

Anticipated date that enrolment will close: December 2018

Who can take part

  • Adults aged between 18 years old to 70 years old
  • People with uncontrolled convulsive seizures
    • Need to have experienced 2 convulsive seizures over 8 weeks -- total 3 over 16 weeks

What is involved for you

  • Blood samples
  • ECG
  • EEG
  • Weight, Blood Pressure, Temperature etc
  • 10 visits in the core study and 11 visits over 2 years in the extension
Phase 1
Phase 2
Phase 3
Phase 4

For more information

Quote reference number
Sean Hosking
03 9342 4657